文献速递生殖医学

促红细胞生成素在卵巢组织移植前后给药对小鼠缺血再灌注的影响

Effects of erythropoietin on ischaemia-reperfusion when administered before and after ovarian tissue transplantation in mice.
PubMed 文献 · Reprod Biomed Online · 2023-05-14

研究将30只瑞士裸鼠分为三组,比较促红细胞生成素在卵巢组织冷冻保存前取材时给药与移植后给药对移植卵巢组织缺血损伤的影响。移植后给药组在移植后14天卵泡活力改善、形态正常生长卵泡数增加,7天增殖卵泡比例更高,血管数和血管占据组织面积增加,移植后7天纤维化面积减少。结论认为移植后给予促红细胞生成素可减轻移植卵巢组织缺血损伤、促进血管生成、维持卵泡增殖并减少纤维化。

要点

  • 移植后给予促红细胞生成素(250 IU/kg,每12小时一次,连续5天)可改善移植后14天卵泡活力并减少退化。
  • 移植后给药组移植后7天增殖卵泡比例、血管数和血管占据组织面积均高于移植前给药组和对照组。
  • 移植前或移植后给予促红细胞生成素均减少移植后7天纤维化面积(P=0.004)。

核心结论

  • 移植后给予促红细胞生成素可减轻移植卵巢组织的缺血损伤,增加血管生成,维持卵泡增殖并减少移植组织纤维化面积。

研究设计与样本

  • 研究纳入30只瑞士裸鼠(nu/nu),分为治疗对照组(n=10)、促红细胞生成素移植前给药组(EPO-BH,n=10)和促红细胞生成素移植后给药组(EPO-AT,n=10)。
  • 动物行双侧卵巢子宫切除术,半卵巢采用慢速冷冻保存,同时将既往冷冻保存的半卵巢移植于背侧皮下。
  • EPO-AT组和EPO-BH组分别每12小时给予促红细胞生成素(250 IU/kg)和 sterile 0.9% 氯化钠溶液,连续5天。

主要发现

  • EPO-AT组移植后14天卵泡活力改善、退化减少、形态正常生长卵泡数增加,与EPO-BH组比较P=0.002。
  • EPO-AT组移植后7天增殖卵泡比例高于EPO-BH组和治疗对照组(P≤0.03)。
  • EPO-AT组移植后7天和14天血管数增加、血管占据组织面积增大,与EPO-BH组和治疗对照组比较P≤0.03。
  • 移植前或移植后给予促红细胞生成素均减少移植后7天纤维化面积(P=0.004)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is the optimal timing for administering erythropoietin to minimize ischaemic injury in ovarian tissue transplantation before ovary removal for cryopreservation and subsequent transplantation or after transplantation? DESIGN: Thirty Swiss mice (nu/nu) were divided into three groups: treatment control group (n = 10); erythropoietin before harvesting group (EPO-BH) (n = 10) and erythropoietin after transplantation group (EPO-AT) (n = 10). Animals underwent bilateral ovariohysterectomy and their hemiovaries were cryopreserved by slow freezing. At the same time, previously cryopreserved hemiovaries were transplanted subcutaneously in the dorsal region. Erythropoietin (250 IU/kg) and sterile 0.9% saline solution were administered every 12/12 h over 5 consecutive days in the EPO-AT and EPO-BH groups, respectively. RESULTS: Administration of erythropoietin in the EPO-AT group improved the viability of ovarian follicles, reducing degeneration and increasing the number of morphologically normal growing follicles at 14 days after transplantation compared with the EPO-BH group (P = 0.002). This group also showed higher percentages of proliferative follicles at 7 days after transplantation (P ≤ 0.03), increased blood vessel count (P ≤ 0.03) and greater tissue area occupied by blood vessels at days 7 and 14 after transplantation (P ≤ 0.03), compared with hormone administration before cryopreservation (EPO-BH group) and the treatment control group. Additionally, treatment with erythropoietin before or after transplantation reduced fibrotic areas at 7 days after transplantation (P = 0.004). CONCLUSION: Erythropoietin treatment after transplantation reduced ischaemic damage in transplanted ovarian tissue, increased angiogenesis, maintenance of ovarian follicle proliferation and reduced fibrosis areas in the grafted tissue.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Rodrigues AQ, Silva IM, Goulart JT, et al. Effects of erythropoietin on ischaemia-reperfusion when administered before and after ovarian tissue transplantation in mice. Reprod Biomed Online. 2023. PMID: 37524029. doi:10.1016/j.rbmo.2023.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。